Immediate Impact
1 from Science/Nature 69 standout
Citing Papers
Regulation of cGAS–STING signalling and its diversity of cellular outcomes
2025 Standout
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
2022 Standout
Works of M. Fuß being referenced
N-MYC impairs innate immune signaling in high-grade serous ovarian carcinoma
2024
Radiochirurgie des Glioblastoma multiforme in der Rezidivsituation
1998
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| M. Fuß | 125 | 363 | 98 | 280 | 145 | 37 | 484 | |
| Stephen Karlovits | 77 | 296 | 60 | 204 | 135 | 39 | 478 | |
| Douglas Guedes de Castro | 66 | 235 | 122 | 301 | 131 | 46 | 511 | |
| Albert Sabbas | 134 | 263 | 85 | 167 | 106 | 30 | 437 | |
| R.J. McCammon | 174 | 336 | 84 | 119 | 70 | 20 | 485 | |
| Sunil W. Dutta | 119 | 166 | 110 | 113 | 62 | 49 | 456 | |
| D. Delishaj | 83 | 140 | 89 | 102 | 165 | 35 | 430 | |
| C. Hashizume | 268 | 346 | 182 | 123 | 100 | 34 | 572 | |
| George Shenouda | 221 | 272 | 179 | 114 | 79 | 40 | 539 | |
| V. Frascino | 158 | 234 | 138 | 134 | 55 | 41 | 439 | |
| Teresa Falco | 72 | 198 | 150 | 98 | 166 | 25 | 517 |
All Works
Login with ORCID to disown or claim papers
Loading papers...